Cargando…
Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells
PURPOSE: This study aims to investigate the possibility of using epigenetic inhibitors against lung cancer. METHODS: The changes in the proliferation of human lung cancer cells, NCI-H1975 and NCI-H1299 cells, treated with various doses of inhibitors of DNA methyltransferase (azacitidine [5-AZA]) or...
Autores principales: | Yang, Yang, Yin, Wei, Wu, Fengying, Fan, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476757/ https://www.ncbi.nlm.nih.gov/pubmed/28652781 http://dx.doi.org/10.2147/OTT.S136218 |
Ejemplares similares
-
Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells
por: Zhang, Xi-Feng, et al.
Publicado: (2016) -
Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy
por: Tang, Dongfang, et al.
Publicado: (2018) -
Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line
por: Zhang, Xuan, et al.
Publicado: (2015) -
Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
por: Chang, J, et al.
Publicado: (2012) -
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model
por: Ramsey, Haley E., et al.
Publicado: (2020)